MedPath

Zopiclone

Generic Name
Zopiclone
Brand Names
Imovane
Drug Type
Small Molecule
Chemical Formula
C17H17ClN6O3
CAS Number
43200-80-2
Unique Ingredient Identifier
03A5ORL08Q

Overview

Zopiclone is a novel hypnotic agent used in the treatment of insomnia. Its mechanism of action is based on modulating benzodiazepine receptors. In addition to zopiclone's benzodiazepine pharmacological properties it also has some barbiturate-like properties.

Indication

For the short-term treatment of insomnia.

Associated Conditions

  • Insomnia

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/01/23
Phase 1
Completed
2023/04/19
Phase 1
Completed
2022/03/14
N/A
Completed
Salem Anaesthesia Pain Clinic
2021/01/06
Phase 1
Completed
2020/06/30
Phase 1
Completed
2019/03/27
Phase 1
Completed
2018/08/15
Phase 1
UNKNOWN
Petri Vainio
2017/11/22
Not Applicable
Completed
Western University, Canada
2017/11/13
Phase 2
Completed
2016/07/01
Phase 4
Terminated
University Hospital, Grenoble

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
IMOVANE TABLET 7.5 mg
SIN05047P
TABLET, FILM COATED
7.5 mg
5/26/1988
ZOPICLONE TABLET 7.5 mg
SIN11416P
TABLET
7.5 mg
10/27/2000
APO-ZOPICLONE TABLET 7.5 mg
SIN09355P
TABLET, FILM COATED
7.5 mg
5/28/1997

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ZOPICLONE
altamed pharma
02468492
Tablet - Oral
5 MG
8/7/2018
NRA-ZOPICLONE
nora pharma inc
02477378
Tablet - Oral
5 MG
8/30/2018
ZOPICLONE TABLETS
nora pharma inc
02492407
Tablet - Oral
3.75 MG
9/29/2020
ZOPICLONE
angita pharma inc.
02557231
Tablet - Oral
5 MG
N/A
SANDOZ ZOPICLONE TABLET
02008203
Tablet - Oral
7.5 MG
12/31/1996
PMS-ZOPICLONE
02240606
Tablet - Oral
7.5 MG
8/4/1999
NTP-ZOPICLONE
teva canada limited
02381818
Tablet - Oral
5 MG
N/A
JAMP ZOPICLONE
02549298
Tablet - Oral
5 MG
N/A
ACT ZOPICLONE
teva canada limited
02271931
Tablet - Oral
5 MG
11/11/2005
M-ZOPICLONE
mantra pharma inc
02467941
Tablet - Oral
5 MG
4/16/2018

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
DATOLAN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
58549
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ZOPICLONA GRINDEKS 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
89867
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ZOPICLONA GRINDEKS 3,75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
89866
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
LIMOVAN 7,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi Aventis S.A.
58538
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Commercialized
ZOPICLONA GRINDEKS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
89865
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized
ZOPICLONA QUALIGEN 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Neuraxpharm Spain S.L.
76243
COMPRIMIDO RECUBIERTO CON PELÍCULA
Medicamento Sujeto A Prescripción Médica
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.